Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014


International Bioprinting Congress

24 Jul 2014 - 25 Jul 2014 - Singapore, Asia



Bookmark and Share


Select Biosciences South East Asia is pleased to present the inaugural International Bioprinting Congress, which will take place at the Biopolis, Singapore.

The event will present the leading international scientists and thought leaders within this rapidly developing field. Featuring Professor Chua Chee Kai, Chair, School of Mechanical and Aerospace Engineering, Nanyang Technological University and Director Nanyang Additive Manufacturing Centre, Singapore and Professor Makoto Nakamura, Graduate School of Science and Engineering for Research, University of Toyama, Japan as our conference chairs. This event will provide you with a detailed insight into the latest developments and techniques in 3D bioprinting.

During this conference, you will learn about the many advances in 3D bioprinting covering; Additive Manufacturing of Tissues and Biofabrication, Scaffolds and Biomaterials for Tissue Engineering, Biological Laser Printing, Biological Inkjet Printing, Search for the Synergy by Fusion of Bio-Additive Manufacturing and Micro Manufacturing, Cell and Tissue Patterning for Lab-on-a-Chip and Tissue Models plus Additive Manufacturing and Medical Devices.
Scientific presentations will be followed by panel discussions on the day’s topics, providing
a balanced overview of the industry from the varied perspectives of the leading researchers, investors and legislative authorities.

Scientific presentations will be followed by panel discussions on the day’s topics, providing
a balanced overview of the industry from the varied perspectives of the leading researchers, investors and legislative authorities.

A tour of the facilities at the Nanyang Technological University Additive Manufacturing Centre will also be offered. The tour is open to all conference attendees and will take place on Thursday 24th July, with coach transfers leaving the Biopolis at 16:00.

Attending this meeting will give you an excellent opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations.



Further information
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!